Brett Belongia
Corporate Officer/Principal chez ONCORUS, INC.
Profil
Brett Belongia is currently working as Vice President-CMC Operations at Oncorus, Inc. He previously worked as Director-Technical Operations at Momenta Pharmaceuticals, Inc. Dr. Belongia completed his undergraduate degree from the University of Wisconsin and his doctorate degree from the University of Arizona.
Postes actifs de Brett Belongia
| Sociétés | Poste | Début |
|---|---|---|
| ONCORUS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Brett Belongia
| Sociétés | Poste | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Brett Belongia
| University of Arizona | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCORUS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |